Author

Hanne Hella

Norwegian University of Science and Technology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Camilla WolowczykiD· 1 shared Eline MenuiD· 1 shared Ingvild Bergdal MestvedtiD· 1 shared Kashif RasheediD· 1 shared Kristine MisundiD· 1 shared Liv RyaniD· 1 shared Maria YurchenkoiD· 1 shared Terje EspevikiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Camilla WolowczykORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Novel SLAMF1-derived peptide induces apoptosis in multiple myeloma cells by targeting IRF4 transcription factor for degradation

Ingvild Bergdal Mestvedt, Eline Menu, Kristine Misund, Tobias Schmidt Slørdahl, Kashif Rasheed, Camilla Wolowczyk, Hanne Hella, Liv Ryan, Therese Standal, Terje Espevik, Maria Yurchenko

This study identifies a SLAMF1-derived peptide, P7N4, that induces apoptosis in multiple myeloma cells by degrading IRF4, enhancing chemotherapy efficacy and showing minimal toxicity to healthy cells.

bioRxiv · May 7, 2025 · PreprintCancer Biology